Publications
Dr Jonathan Morton, Communications Director of our Rare and Orphan Diseases Practice, will be speaking at the World Orphan Drug Congress in November. In the interview below, he provides an insight into the upcoming panel discussion at this congress, as well what he hopes to achieve in order to improve standards of care for patients […]
Read MoreFollowing on from his ALS Ice Bucket Challenge, Oxford PharmaGenesis Commercial Director Dr Richard White will be taking part in the Oxford to Cambridge bike ride on Saturday 27 September to raise money for the British Heart Foundation. “Unfortunately, cardiovascular disease runs in my family,” said Richard, who took up road cycling last year in […]
Read MoreIf anyone has any connection with the world of social media, they will be aware of the viral craze going around … the #icebucketchallenge in aid of the Amyotrophic Lateral Sclerosis Association.
Read MoreOxford PharmaGenesis staff gathered at group headquarters in Oxford this week for the company’s annual summer party.
Read MoreThe need for an integrated, multidisciplinary approach to drug development, healthcare policy and decision-making was a recurring theme of the Westminster Business Forum Keynote Seminar on UK health life sciences, attended by Oxford PharmaGenesis this week in Whitehall, London, UK. This strongly supports the HealthScience concept developed by Oxford PharmaGenesis, which combines the clinical and […]
Read MoreA pioneering systematic methodology to identify observational data sources for specific needs has been presented by Oxford PharmaGenesis today at ISPOR’s 19th Annual International Meeting in Montreal, Canada.
Read MoreA pioneering method to identify and recommend bespoke data sources for global programmes of real-world evidence is being presented at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).
Read MoreOxford PharmaGenesis™ will be showcasing its new HealthScience approach to demonstrating product value and achieving market access at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).
Read MoreOxford PharmaGenesis Value Demonstration Practice is proud to be an exhibitor once again at this year’s ISPOR International Meeting in Montreal, Canada.
Read MoreLeading independent consultancy Oxford PharmaGenesis is pioneering the innovative discipline of HealthScience. For the first time, this integrates the clinical and scientific dimensions of healthcare with the economic, social, behavioural and political perspectives that determine the value of new medicines and health interventions.
Read More